These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17052870)

  • 1. Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation.
    Chiou H; Li L; Hu T; Chan HK; Chen JF; Yun J
    Int J Pharm; 2007 Feb; 331(1):93-8. PubMed ID: 17052870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of inhalable salbutamol sulphate using reactive high gravity controlled precipitation.
    Hu T; Chiou H; Chan HK; Chen JF; Yun J
    J Pharm Sci; 2008 Feb; 97(2):944-9. PubMed ID: 17722000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery.
    Dhumal RS; Biradar SV; Paradkar AR; York P
    Int J Pharm; 2009 Feb; 368(1-2):129-37. PubMed ID: 18996462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
    Kaialy W; Martin GP; Ticehurst MD; Momin MN; Nokhodchi A
    Int J Pharm; 2010 Jun; 392(1-2):178-88. PubMed ID: 20363301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate.
    Shariare MH; de Matas M; York P
    Int J Pharm; 2011 Aug; 415(1-2):62-72. PubMed ID: 21683128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine.
    Najafabadi AR; Gilani K; Barghi M; Rafiee-Tehrani M
    Int J Pharm; 2004 Nov; 285(1-2):97-108. PubMed ID: 15488683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
    J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J; Ng WK; Dong Y; Shen S; Tan RB
    Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.
    Kaialy W; Martin GP; Larhrib H; Ticehurst MD; Kolosionek E; Nokhodchi A
    Colloids Surf B Biointerfaces; 2012 Jan; 89():29-39. PubMed ID: 21962946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation.
    Li L; Leung SSY; Gengenbach T; Yu J; Gao GF; Tang P; Zhou QT; Chan HK
    Int J Pharm; 2017 Sep; 530(1-2):30-39. PubMed ID: 28709940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders.
    Raula J; Lähde A; Kauppinen EI
    Int J Pharm; 2009 Jan; 365(1-2):18-25. PubMed ID: 18789380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler.
    Kaialy W; Momin MN; Ticehurst MD; Murphy J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Sep; 79(2):345-56. PubMed ID: 20537870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does carrier size matter? A fundamental study of drug aerosolisation from carrier based dry powder inhalation systems.
    Ooi J; Traini D; Hoe S; Wong W; Young PM
    Int J Pharm; 2011 Jul; 413(1-2):1-9. PubMed ID: 21501674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H; Young PM; Chan HK; Agus H; Traini D
    Eur J Pharm Sci; 2010 Jun; 40(3):239-47. PubMed ID: 20371286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation and aerosolisation of mannitol particles produced via confined liquid impinging jets.
    Tang P; Chan HK; Chiou H; Ogawa K; Jones MD; Adi H; Buckton G; Prud'homme RK; Raper JA
    Int J Pharm; 2009 Feb; 367(1-2):51-7. PubMed ID: 18848874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.